Ovulation induction disrupts luteal phase function.
Tavaniotou A, Smitz J, Bourgain C, Devroey P.
Centre for Reproductive Medicine, Dutch-Speaking Free University of Brussels, Belgium.
Ann. N. Y. Acad. Sci. 2001: Sep. 943: 55-63
Abstract
Abnormalities in the luteal phase have been detected in virtually all the stimulation protocols used in in vitro fertilization, on both the hormonal and endometrial levels. Supraphysiological follicular or luteal sex steroid serum concentrations, altered estradiol: progesterone (E2/P) ratio, and disturbed luteinizing hormone pituitary secretion leading to corpus luteum insufficiency or a direct drug effect have been postulated as the main etiologic factors. Luteinizing hormone supports corpus luteum function, and low LH levels have been described after human menopausal gonadotropin treatment, after gonadotropin-releasing hormone (GnRH)-agonist treatment, or after GnRH-antagonist treatment. These low luteal LH levels may lead to an insufficient corpus luteum function and consequently to a shortened luteal phase or to the low luteal progesterone concentrations frequently described after ovulation induction. A direct effect of the GnRH agonist or GnRH antagonist on human corpus luteum or on human endometrium and thus on endometrial receptivity cannot be excluded, as GnRH receptors have been described in both compartments. Endometrial histology has revealed a wide range of abnormalities during the various stimulation protocols. In GnRH-agonist cycles, mid-luteal biopsies have revealed increased glandulo-stromal dyssynchrony and delay in endometrial development, strong positivity of endometrial glands for progesterone receptors, decreased alphavbeta3-integrin subunit expression, and earlier appearance of surface epithelium pinopodes. These factors suggest a shift forwards of the implantation window. Progesterone supplementation improves endometrial histology, and its necessity has been well established, at least in cycles using GnRH agonists.
Publications abstracts in peer reviewed journals
-
Cecal volvulus after twin gestation: laparoscopic approach
-
Comparison between different routes of progesterone administration as luteal phase support in infertility treatments
-
Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
-
Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
-
Endometrial hormone receptors and proliferation index on the day of ovum pick-up in GnRH analogue/hMG stimulated cycles with embryo transfer. Comparison to natural cycles and relation to clinical pregnancies
-
Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization.
-
GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial
-
Impact of ovarian stimulation on corpus luteum function and embryonic implantation
-
Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients
-
Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
-
Ovulation induction disrupts luteal phase function.
-
The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate / gonadotrophin / 0.25 mg cetrorelix